drugset / Trial / NCT00079638
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness of first-line treatment using Niaspan (an extended release version of niacin) and statins versus other drugs that lower lipid levels, in subjects with elevated fat levels in their blood (dyslipidemia). Statins are a class of medication that is often prescribed to patients who need to lower their cholesterol levels.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Subject | Niacin | Small molecule | 1000 mg | — |
| Subject | Niacin | Small molecule | 2000 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Rosuvastatin | Small molecule | 40 mg | — |
| Subject | Simvastatin | Small molecule | 40 mg | — |